[14C]-TAK-906 Oral Solution: Clinical Trials

1 completed. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1

Follow [14C]-TAK-906 Oral Solution: new trials by email Literature Review of [14C]-TAK-906 Oral Solution trials Research Report on [14C]-TAK-906 Oral Solution

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants TAK-906 Oral Capsule, [14C]-TAK-906 Intravenous Infusion, [14C]-TAK-906 Oral Solution - Healthy Volunteers	Phase 1	Completed	Millennium Pharmaceuticals, Inc.	6	2020-07-30	2022-03-07

Sponsors

Millennium Pharmaceuticals, Inc. (1)

Countries

United States (1)